Abstract
Yoga is highly sought after by people seeking oncology care, endorsed by clinical practice guidelines, and supported by leading cancer organizations, yet barriers related to access, time, cost, and availability of quality providers remain. Shared medical appointments (SMA), a group healthcare model where patients with similar medical conditions participate in a collective appointment with healthcare providers, are associated with increased access to quality care, patient satisfaction, and clinician satisfaction. We piloted a unique insurance-covered virtual yoga SMA series to assess feasibility and acceptability in a mixed-diagnosis population. In this prospective cohort pilot, a trauma-informed Hanna Somatic Yoga instructor and an integrative medicine physician co-led yoga SMAs via live web-based conferencing. SMA content included conscious self-regulation through mind-body practices including breathing, movement, visualization, meditation, chanting, and guided relaxation. Qualitative and quantitative data were gathered to assess satisfaction with the 88 sessions offered over 33 months. Sixty-nine participants with diverse demographics attended a total of 500 visits. Class attendance ranged from 2-11 participants (mean 6 participants). Participants attended a mean of 7 sessions (range 1-63 sessions), with 63% attending > 1 session. Participants' diagnoses/symptoms included cancer (77%), anxiety/depression (38%), and pain (38%). Preseries, participants reported pain, weakness, neuropathy, lymphedema, insomnia, and fatigue. Postseries survey results suggested improvements in anxiety/fear, pain, fatigue, poor sleep, neuropathy, brain fog, isolation, weakness, inflexibility, and poor balance. Postseries, participants also reported incorporating mindfulness, breathing techniques, somatic skills, weight training, and yoga into their daily routines, with 91% reporting that their goals had been met. Participants appreciated remote delivery, learning new skills, community, and the instructors. This virtual yoga SMA series in a diverse population with mixed diagnoses was feasible, acceptable to participants, and showed promising positive impact. A larger randomized controlled trial with longer follow-up is recommended.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.